Andrew Blumenfeld

Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study ( <scp>IBMS‐II</scp> )

Andrew Blumenfeld, Lisa Bloudek, Werner J. Becker et al. · Headache The Journal of Head and Face Pain · 2013 · 390 citations

Medicine, Pharmacology, Pharmacotherapy +16

Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS)

Lisa Bloudek, Michael Stokes, Dawn C. Buse et al. · The Journal of Headache and Pain · 2012 · 344 citations · Full text

Pharmacy, Neurology, Pharmacoeconomics +17

Cost of Health Care Among Patients With Chronic and Episodic Migraine in Canada and the USA: Results From the International Burden of Migraine Study (IBMS)

Michael Stokes, Werner J. Becker, Richard B. Lipton et al. · Headache The Journal of Head and Face Pain · 2011 · 259 citations

Pharmacy, Neurology, Pharmacoeconomics +15

Method of Injection of OnabotulinumtoxinA for Chronic Migraine: A Safe, Well‐Tolerated, and Effective Treatment Paradigm Based on the PREEMPT Clinical Program

Andrew Blumenfeld, Stephen D. Silberstein, David W. Dodick et al. · Headache The Journal of Head and Face Pain · 2010 · 249 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline

Stephen D. Silberstein, Andrew Blumenfeld, Roger Cady et al. · Journal of the Neurological Sciences · 2013 · 215 citations

Pharmacy, Pharmacology, Pharmacotherapy +13